Copegus (Ribavirin) - Hospitalization - Suspected Cause - Side Effect Reports

Possible Copegus side effects in female

Reported by a physician from France on 2012-08-27

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Mucosal Ulceration, Purpura, Rash Maculo-Papular, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: dosage form: injection
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-07-17

Copegus
    Dosage: dosage form: tablets
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-07-17

Incivek
    Dosage: dosage form: tablet
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-07-15

Incivek
    Dosage: dosage form: tablet
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-07-15

Possible Copegus side effects in male

Reported by a physician from France on 2012-08-24

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Pancreatitis Acute, Pancreatic Necrosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-27
    End date: 2012-01-23

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-27
    End date: 2012-01-23

Incivek
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-27
    End date: 2012-01-23

Dedrogyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-12-08

Other drugs received by patient: Neorecormon

Possible Copegus side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Urinary Tract Infection, Anaemia, Pain, Transfusion, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys

Copegus
    Administration route: Oral

Victrelis

Atenolol
    Administration route: Oral

Other drugs received by patient: Benazepril Hydrochloride; Allopurinol; Estrogens (Unspecified)

Possible Copegus side effects in female

Reported by a physician from Mexico on 2012-08-24

Patient: female, weighing 58.5 kg (128.7 pounds)

Reactions: Anaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
VX-950
    Dosage: 1125 mg, qd
    Indication: Hepatitis C
    Start date: 2011-05-30
    End date: 2011-08-22

Copegus
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2011-08-31
    End date: 2011-11-13

Pegasys
    Dosage: 135 a?g, weekly
    Start date: 2011-11-07
    End date: 2011-11-07

Pegasys
    Dosage: 135 a?g, weekly
    Indication: Hepatitis C
    Start date: 2011-07-01
    End date: 2011-10-31

Pegasys
    Dosage: 180 a?g, weekly
    Start date: 2011-05-30
    End date: 2011-06-30

Copegus
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-05-30
    End date: 2011-06-30

Copegus
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-08-22

Copegus
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2011-08-23
    End date: 2011-08-30

Pegasys
    Dosage: 90 a?g, weekly
    Start date: 2011-11-01
    End date: 2011-11-06

Other drugs received by patient: Erythropoetin; Valsartan; Erythropoetin; Nimodipine; Erythropoetin; Troxerutin; Coumarin; Acetaminophen

Possible Copegus side effects in female

Reported by a physician from United States on 2012-08-24

Patient: female

Reactions: Malaise, Dialysis, Congestive Cardiomyopathy, Pyrexia, Cholecystitis, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: tdd: 1200 mg, last dose prior to sae: 03/may/2012
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07

Pegasys
    Dosage: tdd:180 microgram, last dose prior to sae: 03/may/2012
    Indication: Hepatitis C
    Start date: 2012-02-07

Blinded INX-08189
    Dosage: last dose prior to sae: 03/may/2012
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Sumatriptan; Benzocaine; Lisinopril; Lidocaine; Ibuprofen; Ondansetron; Metoprolol Tartrate; Theraflu (Unk Ingredients); Ibuprofen; Ibuprofen; Benadryl; Amoxicillin; Zosyn; Lorazepam; Prednisone TAB; Tylenol; Tylenol; Ambien; Norco; Robitussin (Canada); Dilaudid; Zofran; Methylprednisone (Unk Ingredients); Magnesium Oxide; Ferrous Gluconate; Fentanyl; Hydrocodone Bitartrate; Ibuprofen

Possible Copegus side effects in female

Reported by a physician from Japan on 2012-08-23

Patient: female, weighing 55.5 kg (122.1 pounds)

Reactions: Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded BI 201335
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-06
    End date: 2012-02-03

Pegasys
    Indication: Hepatitis C
    Start date: 2011-12-06
    End date: 2012-01-30

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-06
    End date: 2012-02-03

Possible Copegus side effects in 75 year old female

Reported by a physician from Japan on 2012-08-23

Patient: 75 year old female

Reactions: Stomatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: dosage is uncertain.
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-08-13

Copegus
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Hepatitis C

Possible Copegus side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Subcutaneous Abscess, Anaemia, Anal Abscess, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: unk
    End date: 2012-01-26

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-25
    End date: 2012-01-26

Pegasys
    Dosage: unk
    End date: 2012-01-26

Possible Copegus side effects in male

Reported by a physician from Romania on 2012-08-23

Patient: male

Reactions: Clinically Isolated Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: last dose prior to sae:28/feb/2012
    Indication: Hepatitis C
    Start date: 2011-05-24

Tg4040
    Dosage: last dose prior to sae:19/sep/2011
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-28

Copegus
    Dosage: last dose prior to sae:04/mar/2012
    Indication: Hepatitis C
    Start date: 2011-05-24

Possible Copegus side effects in

Reported by a consumer/non-health professional from France on 2012-08-23

Patient:

Reactions: Oedema Peripheral, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Administration route: Oral

Copegus
    Administration route: Oral

Victrelis
    Administration route: Oral

Other drugs received by patient: Propranolol; Aldactone; Pantoprazole Sodium; Noroxin

Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Anaemia, Pain, Urinary Tract Infection, Transfusion, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Victrelis
    Administration route: Oral

Pegasys

Atenolol
    Administration route: Oral

Copegus
    Administration route: Oral

Other drugs received by patient: Allopurinol; Estrogens (Unspecified); Victrelis; Benazepril Hydrochloride

Possible Copegus side effects in 67 year old female

Reported by a physician from Japan on 2012-08-22

Patient: 67 year old female

Reactions: Disseminated Intravascular Coagulation, Staphylococcal Sepsis, Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: dosage is uncertain.
    Indication: Hepatitis C

Copegus
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Hepatitis C

Possible Copegus side effects in 49 year old male

Reported by a individual with unspecified qualification from France on 2012-08-22

Patient: 49 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Vomiting, General Physical Health Deterioration, Pyrexia, Multi-Organ Failure, Neutropenia, Asthenia, Septic Shock, Leukopenia, Infectious Peritonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-06-06

Pegasys
    Dosage: 180 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-04-30
    End date: 2012-06-06

Copegus
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2012-04-30
    End date: 2012-06-06

Other drugs received by patient: Vitamin D; Aldactone; Ixel; Neupogen; Delursan; Abilify; Lasix; Revolade

Possible Copegus side effects in female

Reported by a physician from France on 2012-08-22

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gingival Bleeding, Ecchymosis, Anaemia, Rectal Haemorrhage, Thrombocytopenia, Epistaxis, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    End date: 2012-07-03

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-07-03

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-07-03

Pegasys
    End date: 2012-07-03

Other drugs received by patient: Metformin HCL

Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-21

Patient:

Reactions: Rheumatoid Arthritis, Respiratory Disorder, Psychiatric Symptom, Endocrine Disorder, Pancytopenia, Skin Disorder, Neutropenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Indication: Hepatitis C

Pegasys
    Indication: Hepatitis C

Copegus
    Indication: Hepatitis C

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: male

Reactions: Confusional State, Dyspnoea, Disorientation, Rash Pruritic, Loss of Consciousness, Burning Sensation, Malaise, Hypersomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-07-30

Copegus
    Indication: Hepatitis C
    End date: 2012-07-30

Telaprevir
    Indication: Hepatitis C
    End date: 2012-07-30

Possible Copegus side effects in

Reported by a physician from Brazil on 2012-08-21

Patient:

Reactions: Migraine, Pneumonia, Anaemia, Hyponatraemia, Cystitis, Oesophageal Varices Haemorrhage, Syncope, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C

Copegus
    Dosage: for 24 weeks
    Administration route: Oral
    Indication: Hepatitis C

Possible Copegus side effects in 50 year old male

Reported by a physician from Germany on 2012-08-21

Patient: 50 year old male, weighing 91.0 kg (200.2 pounds)

Reactions: Laryngeal Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-22

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-22

Victrelis
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-02

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: male

Reactions: Vomiting, Pneumonia, Swelling Face, Haemorrhage, Anaemia, Bone Swelling, Ill-Defined Disorder, Platelet Count Decreased, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-23

Copegus
    Indication: Hepatitis C
    Start date: 2012-05-23

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-05-23

Possible Copegus side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-06-22

Copegus
    Indication: Hepatitis C

Boceprevir
    Indication: Hepatitis C

Possible Copegus side effects in female

Reported by a physician from Switzerland on 2012-08-20

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Anaemia, Hypotension, Asthenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-20
    End date: 2011-10-11

Blinded BI 201335
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-20
    End date: 2011-10-11

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-20
    End date: 2011-10-11

Other drugs received by patient: Excipial U Lipolotion; Lercanidipine; Losartan Potassium; Nebivolol HCL; Depakene; SUN Bath Protective Tanning Lotion; SUN Bath Protective Tanning Lotion

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: male

Reactions: White Blood Cell Count Decreased, Blood Pressure Decreased, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Copegus
    Indication: Product Used FOR Unknown Indication

Possible Copegus side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-20

Patient: 43 year old male

Reactions: Oedema Peripheral, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Victrelis
    Administration route: Oral

Copegus

Pegasys

Other drugs received by patient: Propranolol; Aldactone; Pantoprazole Sodium; Noroxin

Possible Copegus side effects in male

Reported by a consumer/non-health professional from Chile on 2012-08-20

Patient: male, weighing 84.0 kg (184.8 pounds)

Reactions: Dyspnoea, Muscular Weakness, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-07-20
    End date: 2012-08-10

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-20

Possible Copegus side effects in male

Reported by a physician from Belgium on 2012-08-20

Patient: male, weighing 84.0 kg (184.8 pounds)

Reactions: Back Pain, Pyrexia, Headache, Keratosis Follicular, Myalgia, Neck Pain, Dysuria, Gastroenteritis, Balanitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2011-11-27

Pegasys
    Dosage: last date of administration: 27 nov 2011
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2011-11-27

Copegus
    Dosage: last date of administration: 27 nov 2011
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-10
    End date: 2011-11-27

Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Colitis Ischaemic, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Copegus
    Indication: Product Used FOR Unknown Indication

Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 78.0 kg (171.6 pounds)

Reactions: Mouth Ulceration, Anaemia, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-26

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-26

Blinded BI 201335
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-26

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: male

Reactions: Dysgeusia, Dyspnoea, Coagulopathy, Anaemia, Pulmonary Thrombosis, Factor V Deficiency, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: zydus pharmaceutical
    Indication: Hepatitis C
    Start date: 2012-05-22

Pegasys
    Dosage: proclick autoinjector
    Indication: Hepatitis C
    Start date: 2012-05-22

Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Type 2 Diabetes Mellitus, Pneumonia, Pancreatitis, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Other drugs received by patient: Fosamax; Gabapentin; Acyclovir; Lidex

Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male

Reactions: Sarcoidosis, Hypercalcaemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-12
    End date: 2012-05-16

Blinded Tmc435
    Indication: Hepatitis C
    Start date: 2011-07-12
    End date: 2011-10-05

Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-12
    End date: 2012-05-16

Other drugs received by patient: Protonix; Enalapril Maleate; Aleve; Lovenox